Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracranial Hemorrhage (SAFER-AF)

NCT07316270 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT07316270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07316270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracranial Hemorrhage (SAFER-AF)
Lead sponsor
Beijing Anzhen Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
May 6, 2026
Completion date
January 31, 2030
Enrollment
646 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

af - atrial fibrillation, intracranial hemorrhage, spontaneous